» Articles » PMID: 26669439

MTOR Inhibition Activates Overall Protein Degradation by the Ubiquitin Proteasome System As Well As by Autophagy

Overview
Specialty Science
Date 2015 Dec 17
PMID 26669439
Citations 238
Authors
Affiliations
Soon will be listed here.
Abstract

Growth factors and nutrients enhance protein synthesis and suppress overall protein degradation by activating the protein kinase mammalian target of rapamycin (mTOR). Conversely, nutrient or serum deprivation inhibits mTOR and stimulates protein breakdown by inducing autophagy, which provides the starved cells with amino acids for protein synthesis and energy production. However, it is unclear whether proteolysis by the ubiquitin proteasome system (UPS), which catalyzes most protein degradation in mammalian cells, also increases when mTOR activity decreases. Here we show that inhibiting mTOR with rapamycin or Torin1 rapidly increases the degradation of long-lived cell proteins, but not short-lived ones, by stimulating proteolysis by proteasomes, in addition to autophagy. This enhanced proteasomal degradation required protein ubiquitination, and within 30 min after mTOR inhibition, the cellular content of K48-linked ubiquitinated proteins increased without any change in proteasome content or activity. This rapid increase in UPS-mediated proteolysis continued for many hours and resulted primarily from inhibition of mTORC1 (not mTORC2), but did not require new protein synthesis or key mTOR targets: S6Ks, 4E-BPs, or Ulks. These findings do not support the recent report that mTORC1 inhibition reduces proteolysis by suppressing proteasome expression [Zhang Y, et al. (2014) Nature 513(7518):440-443]. Several growth-related proteins were identified that were ubiquitinated and degraded more rapidly after mTOR inhibition, including HMG-CoA synthase, whose enhanced degradation probably limits cholesterol biosynthesis upon insulin deficiency. Thus, mTOR inhibition coordinately activates the UPS and autophagy, which provide essential amino acids and, together with the enhanced ubiquitination of anabolic proteins, help slow growth.

Citing Articles

Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer's disease.

Cai Y, Kanyo J, Wilson R, Bathla S, Cardozo P, Tong L Nat Aging. 2025; .

PMID: 40065072 DOI: 10.1038/s43587-025-00823-3.


The effect of AKT inhibition in α-synuclein-dependent neurodegeneration.

Ranxhi B, Bangash Z, Chbihi Z, Todi S, LeWitt P, Tsou W Front Mol Neurosci. 2025; 18:1524044.

PMID: 39974188 PMC: 11835820. DOI: 10.3389/fnmol.2025.1524044.


Isolation of Proteins on Chromatin Reveals Signaling Pathway-Dependent Alterations in the DNA-Bound Proteome.

Wang H, Syed A, Krijgsveld J, Sigismondo G Mol Cell Proteomics. 2025; 24(3):100908.

PMID: 39842777 PMC: 11889358. DOI: 10.1016/j.mcpro.2025.100908.


Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs.

Sedlacek J ACS Pharmacol Transl Sci. 2025; 8(1):21-35.

PMID: 39816802 PMC: 11729432. DOI: 10.1021/acsptsci.4c00408.


Activators of the 26S proteasome when protein degradation increases.

Lee D Exp Mol Med. 2025; 57(1):41-49.

PMID: 39779978 PMC: 11799193. DOI: 10.1038/s12276-024-01385-x.


References
1.
Kisselev A, GOLDBERG A . Proteasome inhibitors: from research tools to drug candidates. Chem Biol. 2001; 8(8):739-58. DOI: 10.1016/s1074-5521(01)00056-4. View

2.
Glickman M, Ciechanover A . The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002; 82(2):373-428. DOI: 10.1152/physrev.00027.2001. View

3.
GOLDBERG A . Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy. Biochem Soc Trans. 2007; 35(Pt 1):12-7. DOI: 10.1042/BST0350012. View

4.
Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P . FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007; 6(6):458-71. DOI: 10.1016/j.cmet.2007.11.001. View

5.
Zhao J, Brault J, Schild A, Cao P, Sandri M, Schiaffino S . FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007; 6(6):472-83. DOI: 10.1016/j.cmet.2007.11.004. View